Wikidata

(Q61904718)

English

Trial on the Effect of Isatuximab to Lenaliodomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)

clinical trial

In more languages

Statements

title
A Randomized Phase III Trial Assessing the Benefit of the Addition of Isatuximab to Lenalidomide / Bortezomib / Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma (English)
0 references
country
Germany
0 references
start time
18 October 2018
0 references
end time
May 2025
0 references
number of participants
662
0 references
research intervention
(RS)-lenalidomide
0 references
thalidomide
0 references
bortezomib
0 references
dexamethasone acetate
0 references
(RS)-cyclophosphamide
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61904718&oldid=2109101861"